A detailed history of Pathstone Holdings, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 31,503 shares of ABCL stock, worth $91,988. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,503
Previous 16,810 87.41%
Holding current value
$91,988
Previous $49,000 65.31%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$2.39 - $3.49 $35,116 - $51,278
14,693 Added 87.41%
31,503 $81,000
Q2 2024

Aug 14, 2024

SELL
$2.73 - $4.73 $622 - $1,078
-228 Reduced 1.34%
16,810 $49,000
Q1 2024

May 13, 2024

BUY
$4.29 - $5.97 $1,389 - $1,934
324 Added 1.94%
17,038 $77,000
Q4 2023

Feb 14, 2024

BUY
$3.91 - $5.93 $65,351 - $99,114
16,714 New
16,714 $95,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.